|
UBLCP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.375600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.274390E-01 |
| Normal-vs-Stage2 |
2.293200E-01 |
| Normal-vs-Stage3 |
5.865700E-02 |
| Normal-vs-Stage4 |
4.250000E-02 |
| Stage1-vs-Stage2 |
7.655000E-01 |
| Stage1-vs-Stage3 |
3.944800E-01 |
| Stage1-vs-Stage4 |
2.153400E-01 |
| Stage2-vs-Stage3 |
7.791400E-01 |
| Stage2-vs-Stage4 |
4.454200E-01 |
| Stage3-vs-Stage4 |
5.259400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.193500E-02 |
| Normal-vs-AfricanAmerican |
3.246800E-01 |
| Normal-vs-Asian |
3.700000E-01 |
| Caucasian-vs-AfricanAmerican |
9.329400E-01 |
| Caucasian-vs-Asian |
8.358200E-01 |
| AfricanAmerican-vs-Asian |
9.496000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.658360E-02 |
| Normal-vs-Female |
1.014770E-01 |
| Male-vs-Female |
2.165600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.502420E-01 |
| Normal-vs-Age(41-60Yrs) |
2.131800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.150500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.865800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.066200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.459000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.170800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.648200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.117800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.100400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.507200E-01 |
| Classical-VS-Follicular |
1.940920E-03 |
| Classical-VS-Other |
2.379600E-01 |
| Classical-VS-Normal |
4.091800E-01 |
| Tall-VS-Follicular |
1.415450E-01 |
| Tall-VS-Other |
4.255800E-01 |
| Tall-VS-Normal |
5.736000E-01 |
| Follicular-VS-Other |
9.098400E-01 |
| Follicular-VS-Normal |
2.797200E-03 |
| Other-VS-Normal |
2.820000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.517500E-02 |
| Normal-vs-N1 |
1.212370E-01 |
| N0-vs-N1 |
8.485200E-01 |
|
|
